Clinical Trials Browser

OTHER × Imiquimod × 30 days × Clear all

NCT03276832 2026-03-19

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

Phase EARLY_PHASE1 Completed

7 enrolled 11 charts

Melanoma

NCT07210775 2026-03-04

Topical Imiquimod Treatment of Oral Dysplasia

Phase 1/2 Recruiting

DermatologicHead & Neck

Leukoplakia, Leukokeratosis, Hereditary Mucosal